Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis
AJW Te Velthuis, E Fodor - Nature Reviews Microbiology, 2016 - nature.com
The genomes of influenza viruses consist of multiple segments of single-stranded negative-
sense RNA. Each of these segments is bound by the heterotrimeric viral RNA-dependent …
sense RNA. Each of these segments is bound by the heterotrimeric viral RNA-dependent …
Targeting metalloenzymes for therapeutic intervention
AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein
C Chang, SC Lo, YS Wang, MH Hou - Drug discovery today, 2016 - Elsevier
Highlights•Coronavirus nucleocapsid proteins are appealing drug targets against
coronavirus-induced diseases.•A variety of compounds targeting the coronavirus …
coronavirus-induced diseases.•A variety of compounds targeting the coronavirus …
Treating influenza infection, from now and into the future
S Davidson - Frontiers in immunology, 2018 - frontiersin.org
Influenza viruses (IVs) are a continual threat to global health. The high mutation rate of the IV
genome makes this virus incredibly successful, genetic drift allows for annual epidemics …
genome makes this virus incredibly successful, genetic drift allows for annual epidemics …
Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2
Abstract The Coronavirus Disease 2019, caused by the severe acute respiratory syndrome
coronavirus 2 is an exceptionally contagious disease that leads to global epidemics with …
coronavirus 2 is an exceptionally contagious disease that leads to global epidemics with …
Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations
The outbreak of COVID-19 caused by SARS-CoV-2 virus continually led to infect a large
population worldwide. Currently, there is no specific viral protein-targeted therapeutics. The …
population worldwide. Currently, there is no specific viral protein-targeted therapeutics. The …
Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives
H Ju, J Zhang, B Huang, D Kang, B Huang… - Journal of Medicinal …, 2017 - ACS Publications
Influenza virus (IFV) causes periodic global influenza pandemics, resulting in substantial
socioeconomic loss and burden on medical facilities. Yearly variation in the effectiveness of …
socioeconomic loss and burden on medical facilities. Yearly variation in the effectiveness of …
Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target
Y Hu, H Sneyd, R Dekant… - Current topics in medicinal …, 2017 - ingentaconnect.com
Prevention and treatment of influenza virus infection is an ongoing unmet medical need.
Each year, thousands of deaths and millions of hospitalizations are attributed to influenza …
Each year, thousands of deaths and millions of hospitalizations are attributed to influenza …
Investigational hemagglutinin-targeted influenza virus inhibitors
LY Zeng, J Yang, S Liu - Expert opinion on investigational drugs, 2017 - Taylor & Francis
Introduction: Seasonal influenza and pandemic outbreaks typically result in high mortality
and morbidity associated with severe economic burdens. Vaccines and anti-influenza drugs …
and morbidity associated with severe economic burdens. Vaccines and anti-influenza drugs …
Fragment-based identification of influenza endonuclease inhibitors
CV Credille, Y Chen, SM Cohen - Journal of medicinal chemistry, 2016 - ACS Publications
The influenza virus is responsible for millions of cases of severe illness annually. Yearly
variance in the effectiveness of vaccination, coupled with emerging drug resistance …
variance in the effectiveness of vaccination, coupled with emerging drug resistance …